Bryan K. Sorensen

856 citations

24 papers · 512 indexed · h-index 13

Co-authors: J. T. Link Thomas W von Geldern William J. Chiou Terry J. Opgenorth Andrew S. Tasker Martin Winn Kennan C. Marsh Douglas B. Dixon
Topics: Nitric Oxide and Endothelin Effects (7 papers)Estrogen and related hormone effects (5 papers)Receptor Mechanisms and Signaling (5 papers)
Cited by: Biochemistry Endocrinology, Diabetes and Metabolism Physiology
Journals: Journal of Medicinal Chemistry The Journal of Organic Chemistry Tetrahedron Letters
Partner nations: United States United Kingdom

In The Last Decade

Bryan K. Sorensen

23 papers receiving 476 citations

Peers

Countries citing papers authored by Bryan K. Sorensen

Since Specialization

Citations

This map shows the geographic impact of Bryan K. Sorensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan K. Sorensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan K. Sorensen more than expected).

Fields of papers citing papers by Bryan K. Sorensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan K. Sorensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan K. Sorensen. The network helps show where Bryan K. Sorensen may publish in the future.

Co-authorship network of co-authors of Bryan K. Sorensen

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan K. Sorensen. A scholar is included among the top collaborators of Bryan K. Sorensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan K. Sorensen. Bryan K. Sorensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stereoselective Synthesis of ABBV-992 Enabled by a Flow Diazotization and a Partial Reduction of a Pyridone 2024 ·Organic Process Research & Development ·(unknown),Kaid C. Harper,Bryan K. Sorensen,Stephen N. Greszler,Chunqiu Lai,Alan S. Florjancic,(unknown),(unknown),(unknown),Rodger F. Henry,Terkel Hansen	0
2	Enabling, Decagram-Scale Synthesis of Macrocyclic MCL-1 Inhibitor ABBV-467 2023 ·The Journal of Organic Chemistry ·(unknown),Bryan K. Sorensen,Roberto M. Risi,Michael L. Curtin,Robert A. Mantei,Alan S. Florjancic,Anthony Mastracchio,(unknown),Aaron Kunzer,Chunqiu Lai,(unknown),Vincent Chan,Rodger F. Henry,Andrew J. Souers,Michael R. Michaelides,Andrew S. Judd,Terkel Hansen	3
3	Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases 2010 ·Bioorganic & Medicinal Chemistry Letters ·Steve Fidanze,Scott Erickson,Gary T. Wang,Robert A. Mantei,Richard F. Clark,Bryan K. Sorensen,Nwe Y. BaMaung,Peter Kovar,Eric F. Johnson,Kerren K. Swinger,Kent D. Stewart,Qian Zhang,Lora A. Tucker,William N. Pappano,Julie L. Wilsbacher,Jieyi Wang,George S. Sheppard,Randy L. Bell,Steven K. Davidsen,Robert D. Hubbard	50
4	Adamantane 11-β-HSD-1 inhibitors: Application of an isocyanide multicomponent reaction 2006 ·Bioorganic & Medicinal Chemistry Letters ·Bryan K. Sorensen,(unknown),Jiahong Wang,Steven Fung,(unknown),William J. Chiou,Liping Pan,X.Q. Deng,DeAnne Stolarik,Ernst U. Frevert,Peer B. Jacobson,J. T. Link	30
5	Discovery of potent and selective inhibitors of 11β-HSD1 for the treatment of metabolic syndrome 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Bryan K. Sorensen,Hwan-Soo Jae,(unknown),Yixian Chen,Jiahong Wang,Steven Fung,(unknown),Ernst U. Frevert,Peer B. Jacobson,Hing L. Sham,J. T. Link	17
6	Antidiabetic Activity of Passive Nonsteroidal Glucocorticoid Receptor Modulators 2005 ·Journal of Medicinal Chemistry ·J. T. Link,Bryan K. Sorensen,(unknown),Marlena Grynfarb,Annika Goos‐Nilsson,Jiahong Wang,Steven Fung,Denise Wilcox,(unknown),Phong Nguyen,(unknown),James M. Schmidt,Sue Swanson,(unknown),Thomas Reisch,(unknown),Jia Du,Benjamin C. Lane,Thomas W von Geldern,Peer B. Jacobson	28
7	Optimization and metabolic stabilization of a class of nonsteroidal glucocorticoid modulators 2004 ·Bioorganic & Medicinal Chemistry Letters ·J. T. Link,Bryan K. Sorensen,(unknown),David L. Arendsen,Gaoquan Li,(unknown),Bach Nguyen,Maurice G. Emery,Marlena Grynfarb,Annika Goos‐Nilsson	8
8	Biaryl amide glucagon receptor antagonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Ravi Kurukulasuriya,Bryan K. Sorensen,J. T. Link,(unknown),Hwan-Soo Jae,(unknown),(unknown),(unknown),Chun Wel Lin,(unknown),Andrew Adler,Christine A. Collins	21
9	Bile acid conjugates of a nonsteroidal glucocorticoid receptor modulator 2004 ·Bioorganic & Medicinal Chemistry Letters ·Noah P. Tu,J. T. Link,Bryan K. Sorensen,Maurice G. Emery,Marlena Grynfarb,Annika Goos‐Nilsson,Bach Nguyen	4
10	Synthesis, activity, metabolic stability, and pharmacokinetics of glucocorticoid receptor modulator–statin hybrids 2004 ·Bioorganic & Medicinal Chemistry Letters ·J. T. Link,Bryan K. Sorensen,Chunqiu Lai,(unknown),Steven Fung,(unknown),Maurice G. Emery,(unknown),Marlena Grynfarb,Annika Goos‐Nilsson,(unknown)	9
11	Discovery of novel nonsteroidal glucocorticoid receptor modulators 2004 ·Bioorganic & Medicinal Chemistry Letters ·J. T. Link,Bryan K. Sorensen,(unknown),Maurice G. Emery,Marlena Grynfarb,Annika Goos‐Nilsson	12
12	An Evaluation of a C-Glucuronide as a liver targeting group: conjugate of a glucocorticoid antagonist 2003 ·Bioorganic & Medicinal Chemistry Letters ·Bryan K. Sorensen,J. T. Link,(unknown),Maurice G. Emery,Jiahong Wang,(unknown),Marlena Grynfarb,Annika Goos‐Nilsson,(unknown)	9
13	Discovery and SAR of diarylsulfide cyclopropylamide LFA-1/ICAM-1 interaction antagonists 2001 ·Bioorganic & Medicinal Chemistry Letters ·J. T. Link,Bryan K. Sorensen,Gang Liu,Zhonghua Pei,Edward B. Reilly,Sandra Leitza,(unknown)	19
14	Pyrrolidine-3-carboxylic Acids as Endothelin Antagonists. 5. Highly Selective, Potent, and Orally Active ET_A Antagonists 2001 ·Journal of Medicinal Chemistry ·Hwan-Soo Jae,Martin Winn,Thomas W von Geldern,Bryan K. Sorensen,William J. Chiou,Bach Nguyen,Kennan C. Marsh,Terry J. Opgenorth	22
15	Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ETA receptor selectivity 1999 ·Bioorganic & Medicinal Chemistry ·Steven A. Boyd,Robert A. Mantei,Andrew S. Tasker,Gang Liu,Bryan K. Sorensen,Kenneth J. Henry,Thomas W von Geldern,Martin Winn,Jinshyun R. Wu‐Wong,William J. Chiou,Douglas B. Dixon,Charles W. Hutchins,Kennan C. Marsh,Bach Nguyen,Terry J. Opgenorth	10
16	Potent and Selective Non-Benzodioxole-Containing Endothelin-A Receptor Antagonists 1997 ·Journal of Medicinal Chemistry ·Andrew S. Tasker,Bryan K. Sorensen,Hwan-Soo Jae,Martin Winn,Thomas W von Geldern,Douglas B. Dixon,William J. Chiou,Brian D. Dayton,(unknown),Lisa E. Hernandez,Kennan C. Marsh,Jinshyun R. Wu‐Wong,Terry J. Opgenorth	27
17	2,4-Diarylpyrrolidine-3-carboxylic AcidsPotent ET_A Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722 1996 ·Journal of Medicinal Chemistry ·Martin Winn,Thomas W von Geldern,Terry J. Opgenorth,Hwan-Soo Jae,Andrew S. Tasker,Steven A. Boyd,(unknown),Robert A. Mantei,(unknown),Bryan K. Sorensen,Jinshyun R. Wu‐Wong,William J. Chiou,Douglas B. Dixon,Eugene I. Novosad,Lisa E. Hernandez,Kennan C. Marsh	98
18	[3H]A-81988, a potent, selective, competitive antagonist radioligand for angiotensin AT1 receptors 1994 ·European Journal of Pharmacology Molecular Pharmacology ·(unknown),Bruce W. Surber,(unknown),Samuel Thomas,Andrew S. Tasker,Bryan K. Sorensen,(unknown),T. J. Opgenorth,Daniel J. Kerkman,John F. DeBernardis	3
19	Synthesis and In Vitro evaluation of fused ring heterocyle-containing angiotensin II antagonists. 1994 ·Bioorganic & Medicinal Chemistry Letters ·Thomas M. Zydowsky,Martin Winn,Biswanath De,(unknown),Robert J. Altenbach,Fatima Z. Basha,Steven A. Boyd,Steven A. Buckner,Arthur A. Hancock,Jang Y. Lee,Robert A. Mantei,Eugene I. Novosad,Bryan K. Sorensen,Andrew S. Tasker,Kazumi Shiosaki,Daniel J. Kerkman,Terry J. Opgenorth,John F. DeBernardis	5
20	Potent and selective inhibitors of an aspartyl protease-like endothelin converting enzyme identified in rat lung 1993 ·Journal of Medicinal Chemistry ·Kazumi Shiosaki,Andrew S. Tasker,Gerard M. Sullivan,Bryan K. Sorensen,Thomas W von Geldern,Jinshyun R. Wu‐Wong,(unknown),Terry J. Opgenorth	12

About Bryan K. Sorensen

Bryan K. Sorensen is a scholar working on Biophysics, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 24 papers that have together received 512 indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (7 papers), Estrogen and related hormone effects (5 papers) and Receptor Mechanisms and Signaling (5 papers). The work is most often cited by research in Biochemistry (56 citations), Endocrinology, Diabetes and Metabolism (120 citations) and Physiology (154 citations). Bryan K. Sorensen has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include J. T. Link, Thomas W von Geldern, William J. Chiou, Terry J. Opgenorth, Andrew S. Tasker, Martin Winn, Kennan C. Marsh, Douglas B. Dixon, Hwan-Soo Jae and Bach Nguyen. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact